Placebo-controlled randomised trial with liraglutide on magnetic resonance endpoints in individuals with type 2 diabetes: a pre-specified secondary study on ectopic fat accumulation

Bizino, M.B.; Jazet, I.M.; Heer, P. de; Eyk, H.J. van; Dekkers, I.A.; Rensen, P.C.N.; ... ; Smit, J.W. (2019)

Article / Letter to editor

• Ectopic fat
• Glucagon-like peptide-1 receptor agonist
• Hepatic steatosis
• Liraglutide
• Myocardial steatosis
• Non-alcoholic fatty liver disease
• Type 2 diabetes mellitus

• All authors: Bizino, M.B.; Jazet, I.M.; Heer, P. de; Eyk, H.J. van; Dekkers, I.A.; Rensen, P.C.N.; Paiman, E.H.M.; Lamb, H.J.; Smit, J.W.
• Date: 2019-11-05
• Journal: Diabetologia
• DOI: doi:10.1007/s00125-019-05021-6